²ÝÝ®ÊÓƵ Raises Quarterly Dividend by 15% to $0.82 Per Share
IRVING, Texas, July 30, 2025— The Board of Directors of ²ÝÝ®ÊÓƵ (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.
“²ÝÝ®ÊÓƵ continues our long-standing track record of returning capital to shareholders, marking our ninth consecutive annual dividend increase,” said Brian Tyler, chief executive officer. “These actions reflect our confidence in the strength of our business and reinforces our commitment to delivering long-term value to shareholders.”
About ²ÝÝ®ÊÓƵ
²ÝÝ®ÊÓƵ is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how ²ÝÝ®ÊÓƵ is impacting virtually every aspect of healthcare at ²ÝÝ®ÊÓƵ.com and read Stories & Insights.
We routinely use our website, , to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events.
Related Press Releases
-
²ÝÝ®ÊÓƵ Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets
-
²ÝÝ®ÊÓƵ Declares Quarterly Dividend
-
²ÝÝ®ÊÓƵ Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions
-
²ÝÝ®ÊÓƵ Announces Planned CFO Transition
-
²ÝÝ®ÊÓƵ Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance